CoChat

High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting

Antoun, Sami, Bayar, Amine, Ileana, Ekatarina, Laplanche, Agnès, Fizazi, Karim, di Palma, Mario, Escudier, Bernard, Albiges, Laurence, Massard, Christophe, Loriot, Yohann · 2015 · European Journal of Cancer
Cited by 97

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2015.07.042

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 28

  1. Nelson, 2003, Prostate cancer, N Engl J Med, 349, 366, 10.1056/NEJMra021562 · DOI · Paper page
  2. Attard, 2015, Prostate cancer, Lancet
  3. Gillessen, 2015, Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015, Ann Oncol, 26, 1589, 10.1093/annonc/mdv257 · DOI · Paper page
  4. Armstrong, 2010, Prediction of survival following first-line chemotherapy in men with castration-resistant metastatic prostate cancer, Clin Cancer Res, 16, 203, 10.1158/1078-0432.CCR-09-2514 · DOI · Paper page
  5. Halabi, 2014, Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer, J Clin Oncol, 32, 671, 10.1200/JCO.2013.52.3696 · DOI · Paper page
  6. Smith, 2012, Sarcopenia during androgen-deprivation therapy for prostate cancer, J Clin Oncol, 30, 3271, 10.1200/JCO.2011.38.8850 · DOI · Paper page
  7. Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423 · DOI · Paper page
  8. Rodriguez, 2001, Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States, Cancer Epidemiol Biomarkers Prev, 10, 345
  9. Halabi, 2007, Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer, Cancer, 110, 1478, 10.1002/cncr.22932 · DOI
  10. Tan, 2009, Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer, Clin Cancer Res, 15, 6973, 10.1158/1078-0432.CCR-09-1525 · DOI · Paper page
  11. Lanic, 2014, Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immune chemotherapy, Leuk Lymphoma, 55, 817, 10.3109/10428194.2013.816421 · DOI · Paper page
  12. Steffens, 2011, Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?, Oncologist, 16, 1565, 10.1634/theoncologist.2011-0213 · DOI
  13. Naya, 2010, Influence of visceral obesity on oncologic outcome in patients with renal cell carcinoma, Urol Int, 85, 30, 10.1159/000318988 · DOI
  14. Ladoire, 2011, Visceral fat area as a new independent predictive factor of survival in patients with metastatic renal cell carcinoma treated with antiangiogenic agents, Oncologist, 16, 71, 10.1634/theoncologist.2010-0227 · DOI · Paper page
  15. Fizazi, 2012, Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study, Lancet Oncol, 13, 983, 10.1016/S1470-2045(12)70379-0 · DOI · Paper page
  16. Attard, 2012, Clinical and biochemical consequences of CYP17A1 inhibition with abiraterone given with and without exogenous glucocorticoids in castrate men with advanced prostate cancer, J Clin Endocrinol Metab, 97, 507, 10.1210/jc.2011-2189 · DOI · Paper page
  17. Martin, 2013, Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index, J Clin Oncol, 31, 1539, 10.1200/JCO.2012.45.2722 · DOI · Paper page
  18. Schemper, 1996, A note on quantifying follow-up in studies of failure time, Control Clin Trials, 17, 343, 10.1016/0197-2456(96)00075-X · DOI · Paper page
  19. Altman, 2012, Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration, PLoS Med, 9, e1001216, 10.1371/journal.pmed.1001216 · DOI · Paper page
  20. Chalfin, 2014, Obesity and long-term survival after radical prostatectomy, J Urol, 192, 1100, 10.1016/j.juro.2014.04.086 · doi:10.1016/j.juro.2014.04.086
  21. Gonzalez, 2014, Obesity paradox in cancer: new insights provided by body composition, Am J Clin Nutr, 99, 999, 10.3945/ajcn.113.071399 · DOI · Paper page
  22. Kalantar-Zadeh, 2007, Risk factor paradox in wasting diseases, Curr Opin Clin Nutr Metab Care, 10, 433, 10.1097/MCO.0b013e3281a30594 · DOI · Paper page
  23. Camus, 2014, Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy, Eur J Haematol, 93, 9, 10.1111/ejh.12285 · DOI · Paper page
  24. Bing, 2008, Regulation of adipose tissue metabolism in cancer cachexia, Curr Opin Clin Nutr Metab Care, 11, 201, 10.1097/MCO.0b013e3282f948e2 · DOI
  25. Agustsson, 2007, Mechanism of increased lipolysis in cancer cachexia, Cancer Res, 67, 5531, 10.1158/0008-5472.CAN-06-4585 · DOI · Paper page
  26. Rydén, 2008, Lipolysis – not inflammation, cell death, or lipogenesis – is involved in adipose tissue loss in cancer cachexia, Cancer, 113, 1695, 10.1002/cncr.23802 · DOI · Paper page
  27. Hamilton, 2011, Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy, Clin Endocrinol (Oxf), 74, 377, 10.1111/j.1365-2265.2010.03942.x · DOI · Paper page
  28. Pezaro, 2013, Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer, Br J Cancer, 109, 325, 10.1038/bjc.2013.340 · DOI

Cited by

See all 97

Metadata

Authors
Antoun, S., Bayar, A., Ileana, E., Laplanche, A., Fizazi, K., di Palma, M., Escudier, B., Albiges, L., Massard, C., & Loriot, Y.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2015-11
Volume
51
Issue
17
Pages
2570-2577
ISSN
0959-8049
Cited by
97
References
8
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting. https://app.cochat.ai/papers/10.1016/j.ejca.2015.07.042
The paper
Antoun, S., Bayar, A., Ileana, E., Laplanche, A., Fizazi, K., di Palma, M., Escudier, B., Albiges, L., Massard, C., & Loriot, Y. (2015). High subcutaneous adipose tissue predicts the prognosis in metastatic castration-resistant prostate cancer patients in post chemotherapy setting. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2015.07.042

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.